{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:05:57Z","timestamp":1768568757919,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.4065\/84.2.149","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T18:25:35Z","timestamp":1233339935000},"page":"149-160","source":"Crossref","is-referenced-by-count":17,"title":["Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care"],"prefix":"10.4065","volume":"84","author":[{"given":"Marc","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7329","key":"10.4065\/84.2.149_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"7","key":"10.4065\/84.2.149_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.4065\/84.2.149_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.4065\/84.2.149_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"King","year":"2007","journal-title":"Circulation"},{"issue":"19","key":"10.4065\/84.2.149_bib5","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.4065\/84.2.149_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archinte.164.2.203","article-title":"Get with the guidelines for cardiovascular secondary prevention: pilot results","volume":"164","author":"LaBresh","year":"2004","journal-title":"Arch Intern Med"},{"issue":"17","key":"10.4065\/84.2.149_bib7","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1001\/jama.292.17.2096","article-title":"Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"292","author":"Bhatt","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.4065\/84.2.149_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.287.10.1269","article-title":"Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative","volume":"287","author":"Mehta","year":"2002","journal-title":"JAMA"},{"issue":"18","key":"10.4065\/84.2.149_bib9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.166.18.2027","article-title":"Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative","volume":"166","author":"Mehta","year":"2006","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.4065\/84.2.149_bib10","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1371\/journal.pmed.0020353","article-title":"Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease","volume":"2","author":"Stafford","year":"2005","journal-title":"PLoS Med"},{"issue":"2","key":"10.4065\/84.2.149_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"issue":"23","key":"10.4065\/84.2.149_bib12","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1001\/archinte.1994.00420230032005","article-title":"Adherence to aspirin in the prevention of myocardial infarction: the Physicians' Health Study","volume":"154","author":"Glynn","year":"1994","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.4065\/84.2.149_bib13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"Eur Heart J"},{"issue":"24","key":"10.4065\/84.2.149_bib14","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"issue":"17","key":"10.4065\/84.2.149_bib15","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.4065\/84.2.149_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ahj.2007.04.009","article-title":"Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs","volume":"154","author":"Steinhubl","year":"2007","journal-title":"Am Heart J"},{"issue":"8","key":"10.4065\/84.2.149_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.4065\/84.2.149_bib18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.4065\/84.2.149_bib19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"issue":"12","key":"10.4065\/84.2.149_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.4065\/84.2.149_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.4065\/84.2.149_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) Trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.4065\/84.2.149_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"GUSTO Investigators","year":"1993","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/84.2.149_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2006.07.091","article-title":"Assessment of bleeding events in clinical trials\u2014proposal of a new classification [published correction appears in Am J Cardiol. 2007;100 (3):562]","volume":"99","author":"Serebruany","year":"2007","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.4065\/84.2.149_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2005.09.060","article-title":"A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes","volume":"47","author":"Rao","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.4065\/84.2.149_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11239-007-0182-x","article-title":"Bleeding after antithrombotic therapy in patients with acute ischemic heart disease: is it the drugs or how we use them?","volume":"26","author":"Cohen","year":"2008","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.4065\/84.2.149_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcin.2007.12.006","article-title":"Major femoral bleeding complications after percutaneous coronary interventions: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994-2005","volume":"1","author":"Doyle","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"issue":"7","key":"10.4065\/84.2.149_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1742-1241.2006.00999.x","article-title":"Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial","volume":"60","author":"Serebruany","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.4065\/84.2.149_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2125.2005.02569.x","article-title":"Initial phase of chronic medication use; patients' reasons for discontinuation","volume":"61","author":"Hugtenburg","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.4065\/84.2.149_bib30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.RVI.0000240426.53079.46","volume":"17","author":"Hirsch","year":"2006","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"10.4065\/84.2.149_bib31","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","volume":"113","author":"Sacco","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.4065\/84.2.149_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00129784-200707040-00006","article-title":"Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials","volume":"7","author":"Helton","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"10.4065\/84.2.149_bib33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators","year":"2001","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/84.2.149_bib34","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"9497","key":"10.4065\/84.2.149_bib35","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.4065\/84.2.149_bib36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/84.2.149_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"issue":"8572","key":"10.4065\/84.2.149_bib38","first-page":"1351","article-title":"The European Stroke Prevention Study (ESPS): principal end-points","volume":"2","author":"ESPS Group","year":"1987","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.4065\/84.2.149_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"issue":"9523","key":"10.4065\/84.2.149_bib40","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"ESPRIT Study Group","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"10.4065\/84.2.149_bib41","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Eng J Med"},{"issue":"20","key":"10.4065\/84.2.149_bib42","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"20","key":"10.4065\/84.2.149_bib43","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMe0706859","article-title":"Intensifying platelet inhibition\u2014navigating between scylla and charybdis","volume":"357","author":"Bhatt","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/84.2.149_bib44","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"Cannon","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.4065\/84.2.149_bib45","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"issue":"19","key":"10.4065\/84.2.149_bib46","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","author":"Storey","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.4065\/84.2.149_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.106.177321","volume":"114","author":"Brosius","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.4065\/84.2.149_bib48","first-page":"1343","article-title":"The renal patient with coronary artery disease: current concepts and dilemmas","volume":"44","author":"Gupta","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9356","key":"10.4065\/84.2.149_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(03)12468-3","article-title":"Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial","volume":"361","author":"Thies","year":"2003","journal-title":"Lancet"},{"key":"10.4065\/84.2.149_bib50","author":"US Food and Drug Administration"},{"issue":"3","key":"10.4065\/84.2.149_bib51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4065\/83.3.324","article-title":"Omega-3 fatty acids for cardioprotection","volume":"83","author":"Lee","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"1\u20132","key":"10.4065\/84.2.149_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thromres.2005.04.017","article-title":"Effects of dietary supplements on coagulation and platelet function","volume":"117","author":"Basila","year":"2005","journal-title":"Thromb Res"},{"issue":"24","key":"10.4065\/84.2.149_bib53","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"21","key":"10.4065\/84.2.149_bib54","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.4065\/84.2.149_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJMe048330","article-title":"Reducing the risks of gastrointestinal bleeding with antiplatelet therapies [editorial]","volume":"352","author":"Cryer","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.4065\/84.2.149_bib56","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1053\/j.gastro.2004.08.016","article-title":"Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis","volume":"127","author":"Weideman","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.4065\/84.2.149_bib57","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.amjcard.2007.04.050","article-title":"The \u201cclopidogrel resistance\u201d trap [editorial]","volume":"100","author":"Serebruany","year":"2007","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.4065\/84.2.149_bib58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.psy.0000126199.05189.86","article-title":"Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction","volume":"66","author":"Shemesh","year":"2004","journal-title":"Psychosom Med"},{"issue":"2","key":"10.4065\/84.2.149_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ahj.2003.07.011","article-title":"Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?","volume":"147","author":"Cotter","year":"2004","journal-title":"Am Heart J"},{"issue":"8","key":"10.4065\/84.2.149_bib60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amjcard.2004.12.038","article-title":"Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction","volume":"95","author":"Schwartz","year":"2005","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.4065\/84.2.149_bib61","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1001\/archinte.165.21.2508","article-title":"Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study","volume":"165","author":"Gehi","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.4065\/84.2.149_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ahj.2005.02.038","article-title":"Long-term adherence with cardiovascular drug regimens","volume":"151","author":"Kulkarni","year":"2006","journal-title":"Am Heart J"},{"issue":"6","key":"10.4065\/84.2.149_bib63","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/01.WNL.0000138494.66691.07","article-title":"Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination","volume":"63","author":"Lipton","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.4065\/84.2.149_bib64","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0149-2918(01)80115-6","article-title":"Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke","volume":"23","author":"Redman","year":"2001","journal-title":"Clin Ther"},{"issue":"5","key":"10.4065\/84.2.149_bib65","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-2125.1999.00072.x","article-title":"Rapid development of tolerance to dipyridamole-associated headaches","volume":"48","author":"Theis","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.4065\/84.2.149_bib66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14219\/jada.archive.2000.0176","article-title":"Does low-dose aspirin therapy complicate oral surgical procedures?","volume":"131","author":"Ardekian","year":"2000","journal-title":"J Am Dent Assoc"},{"issue":"11","key":"10.4065\/84.2.149_bib67","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.14219\/jada.archive.2003.0080","article-title":"Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment","volume":"134","author":"Jeske","year":"2003","journal-title":"J Am Dent Assoc"},{"issue":"6","key":"10.4065\/84.2.149_bib68","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2007.01.003","volume":"49","author":"Grines","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.4065\/84.2.149_bib69","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","article-title":"Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis","volume":"257","author":"Burger","year":"2005","journal-title":"J Intern Med"},{"issue":"3","key":"10.4065\/84.2.149_bib70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/bja\/aem209","article-title":"Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction","volume":"99","author":"Chassot","year":"2007","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.4065\/84.2.149_bib71","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/fampra\/cml036","article-title":"\u2018Can I come off the tablets now?\u2019 a qualitative analysis of heart failure patients' understanding of their medication","volume":"23","author":"Field","year":"2006","journal-title":"Fam Pract"},{"issue":"4","key":"10.4065\/84.2.149_bib72","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1160\/TH05-04-0889","article-title":"Effect of compliance and dosage adaptation of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction [letter]","volume":"94","author":"von Pape","year":"2005","journal-title":"Thromb Haemost"},{"issue":"14","key":"10.4065\/84.2.149_bib73","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.4065\/84.2.149_bib74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/hrt.80.5.447","article-title":"Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care","volume":"80","author":"Campbell","year":"1998","journal-title":"Heart"},{"issue":"1","key":"10.4065\/84.2.149_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1331\/1544345052843020","article-title":"Community pharmacy Target Intervention Program to improve aspirin use in persons with diabetes","volume":"45","author":"Haggerty","year":"2005","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"15","key":"10.4065\/84.2.149_bib76","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.287.15.1909","article-title":"The most powerful therapeutic force","volume":"287","author":"Kirsner","year":"2002","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611608239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611608239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:58:16Z","timestamp":1558101496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611608239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0025619611608239"],"URL":"https:\/\/doi.org\/10.4065\/84.2.149","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}